Rules and Regulations. Final rule

Agency: Food and Drug Administration, HHS
Action: Final rule
Citation: FR Doc. 02-19906 · 21 CFR 510

Summary

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Blue Ridge Pharmaceuticals, Inc., to IDEXX Pharmaceuticals, Inc.

Dates

This rule is effective August 7, 2002.

Supplementary Information

Blue Ridge Pharmaceuticals, Inc., 4249-105 Piedmont Pkwy., Greensboro, NC 27410, has informed FDA of a change of name to IDEXX Pharmaceuticals, Inc. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects in 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows: PART 510—NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entry for “Blue Ridge Pharmaceuticals, Inc.” and by alphabetically adding an entry for “IDEXX Pharmaceuticals, Inc.”; and in the table in paragraph (c)(2) by revising the entry for “065274” to read as follows. § 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. (c) * * * (1) * * * Firm name and address Drug labeler code * * * * * * * IDEXX Pharmaceuticals, Inc., 4249-105 Piedmont Pkwy., Greensboro, NC 27410 065274 * * * * * * * (2) * * * Drug labeler code Firm name and address * * * * * * * 065274 IDEXX Pharmaceuticals, Inc., 4249-105 Piedmont Pkwy., Greensboro, NC 27410 * * * * * * * Dated: July 19, 2002. Andrew J. Beaulieu, Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 02-19906 Filed 8-6-02; 8:45 am]